Skip to main content
. 2023 Jul 10;10(2):e000923. doi: 10.1136/lupus-2023-000923

Table 5.

Baseline propensity scores by quartiles and cACEi/cARB use

Quartile Propensity score range Use of cACEi or cARB (no of participants)
Yes No Total at baseline
1 0.00–0.07 3 72 75
2 0.06–0.13 8 67 75
3 0.17–0.23 11 64 75
4 0.23–0.78 31 44 75
Total 53 247 300

cACEi, centrally acting ACE inhibitor; cARB, centrally acting angiotensin receptor blocker.